Le Lézard
Classified in: Health
Subject: PER

Kelly Hover Joins MedCerts as Executive Vice President of Operations and Student Engagement


DETROIT, Jan. 16, 2020 /PRNewswire/ -- MedCerts, one of the nation's leading providers of online career certification training, announces today the addition of Kelly Hover, former University of Phoenix Director, to its executive team.

Hover will assume the role of Executive Vice President of Operations and Student Engagement, a new position created to maximize MedCerts continued focus on outcomes and employer relations.

"I'm in love with the mission of MedCerts and how the company executes. I've been in higher education for 11 years and no one else has solved the problem of placement," Hover said. "MedCerts has a strategy for that and that's why students are coming to them. The company is not just focused on exam prep or pass rates ? MedCerts is a disruptor in the industry, and I am excited to contribute to that."

Previously, Hover acted as Senior Director of Strategy and Customer Experience for the University of Phoenix, where she redesigned their customer service model to better align with its partners and students and created an omnichannel communication strategy. Hover brings a decade of experience in higher education to MedCerts and is relocating to the metro Detroit area from Phoenix for the role.

"We are excited to announce that Kelly will be joining MedCerts," Jason Aubrey, MedCerts CEO, said. "Her experience directly aligns with our continued efforts to be a pioneer in the world of online education and meet the needs of our students, the healthcare industry and our partners."

MedCerts has been focusing efforts on improving efficiencies for students in three key areas ? program completion, exam pass rates and placement ? based on data from the Department of Labor, workforce offices and current partners. These efforts include enhancements to current programs, the launch of Experiential Learning Services and the newly adopted Apprenticeship program.  

About MedCerts:
MedCerts is a national online career training school pioneering the way students learn and employers hire. Focused on direct to consumer certifications in the healthcare and IT fields, the eLearning school helps students gain the skills and knowledge necessary to excel in new careers and deliver employers the right candidates to fit their organization. MedCerts provides certification and career training through HD-quality video-based instruction, virtual simulations, games and animations, and on-the-job training through Experiential Learning Solutions. Since 2009, the company has trained over 19,000 students in over 35 career programs and over 800 organizations are using or hiring these students. For more information, visit: www.medcerts.com

Media Contact
Jon-Eric Cornellier
Director of Marketing
734-469-5236
[email protected]

SOURCE MedCerts


These press releases may also interest you

at 16:10
Acadia Pharmaceuticals Inc. today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. Acadia's management team will also host a conference call and webcast on May 8,...

at 16:10
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May...

at 16:05
BeiGene, Ltd. , a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024....

at 16:05
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024. Webcast and Conference Call and...

at 16:05
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced three accepted abstracts at the 2024 American Society of...



News published on and distributed by: